ANI
ANI
Diversified biopharmaceutical company focused on rare diseases and generics.
About
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics. They are transforming into a leading Rare Disease company, with a focus on ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a strong Generics business leveraging R&D expertise and U.S.-based manufacturing.
Key facts
At-a-glance profile data
- Website
- anipharmaceuticals.com
- Headquarters
- Princeton, United States
- Founded
- 1981
- Employees
- 710
- Total funding
- $11M (Seed)
- Business model
- B2B
- Tags
- BiopharmaceuticalRare DiseaseOphthalmologyGenericsDrug Discovery
Funding rounds
Tech stack
Detected on anipharmaceuticals.com, last scanned 2 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- Cookie consent
- Osano
Add first review
Frequently asked
How much funding has ANI raised?
ANI has raised a total of $11M in funding. The most recent round on record is Seed.
How many employees does ANI have?
ANI has approximately 710 people on record.